Rejuvenation Technologies Inc.

About

Rejuvenation Technologies Inc. is a biotechnology company based in Mountain View, California, established in 2016. The company is dedicated to developing innovative therapies aimed at addressing aging and age-related diseases. Its primary focus is on mRNA-based therapeutics designed to extend healthspan by preventing and treating chronic conditions associated with aging. A notable area of research includes optimized telomerase mRNA encapsulated in custom tissue-targeted lipid nanoparticles, which target telomere shortening. The company has secured substantial funding to support its research and development initiatives, including a $10.6 million seed financing round in 2023 led by Khosla Ventures. Rejuvenation Technologies is advancing its programs toward IND approval for fibrotic diseases and is also exploring early research targeting the immune system. The company aims to expand its operations and enhance its mRNA delivery capabilities across various organ systems.